Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapyPerformed on behalf of the Mortalité 2000 Study Group. Scientific coordination: Geneviève Chêne, Thierry May, Philippe Morlat, Dominique Salmon, Dominique Costagliola, and Eric Jougla. Observers: François Dabis, Jean‐François Delfraissy, Catherine Leport, and Patrick Yéni. Corresponding physicians: Laurence Héripret, Sibylle Bévilacqua, Fabrice Bonnet, and Charlotte Lewden. Technical team: Jean Boileau, Mallorie Dellac, Sylvie Dutoit, and Valérie Mazou. Technical support: Marthe‐Aline Jutand and Gérard Pavillon. Participant wards: Agen (Y. Imbert), Aix‐en‐Provence (T. Allégre and M. Marquiant), Ajaccio (J.F. Abino), Albi (P. Barel), Alés (A. Lagier), Amiens (J.L. Schmit, J.P. Denoeux, and J.F. Poulain), Angers (J.M. Chennebault and J. Loison), Annecy (J.P. Bru and J. Gaillat), Arcachon (A. Dupont), Argenteuil (M. Pulik), Arras (J.F. Bervar), Avignon (G.

Autor: Fabrice Bonnet, Charlotte Lewden, Thierry May, Laurence Heripret, Eric Jougla, Sibylle Bevilacqua, Dominique Costagliola, Dominique Salmon, Geneviève Chêne, Philippe Morlat
Zdroj: Cancer (0008543X); Jul2004, Vol. 101 Issue 2, p317-324, 8p
Databáze: Complementary Index
Externí odkaz: